Siting Zhao, Meilin Jin, Hongchao Li, Yadi Tan, Guihua Wang, Ruihua Zhang, Huanchun Chen
Avian Diseases 49 (4), 488-493, (1 December 2005) https://doi.org/10.1637/7321-010405R1.1
KEYWORDS: avian influenza virus (AIV), nonstructural protein (NS1), antibody, ELISA, AI = avian influenza, AIV = avian influenza virus, bp = base pairs, BSA = bovine serum albumin, ECE = embryonated chicken eggs, ELISA = enzyme-linked immunosorbent assay, FAV = fowl adenovirus, HEPA = high-efficiency particulate air, HI = hemagglutinin-inhibition, HPAI = high pathogenicity AI, HRP = horseradish peroxidase, IB = infectious bronchitis, IBD = infectious bursal disease, ILT = infectious laryngotracheitis, IPTG = isopropyl-β-D-galactopyranoside, LPAI = low pathogenicity AI, MD = Marek's disease, NS1 = nonstructural protein, ND = Newcastle disease, NI = neuraminidase-inhibition, OD = optical density, RDE = receptor-destroying enzyme, RT-PCR = reverse transcription-polymerase chain reaction, SPF = specific-pathogen-free, TBS = Tris-buffered saline
To differentiate avian influenza virus (AIV)-infected chickens vs. chickens immunized with inactivated avian influenza virus, an enzyme-linked immunosorbent assay (ELISA) was developed using a recombinant nonstructural protein (NS1) as the diagnostic antigen, which was cloned from an AIV H9N2 subtype strain isolated during the avian influenza outbreak of 2003–04 and expressed in Escherichia coli. Antibodies to the AIV NS1 protein was only detected in the sera of chickens experimentally infected with AIV but not in the sera of chickens immunized with inactivated vaccine. This ELISA is useful for serological diagnosis to distinguish chickens infected with influenza viruses from those immunized with inactivated vaccine.